Cirrhosis and its complications: Evidence based treatment

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 18

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

1830

WORD

304

HTML

15143

Tables (1-4)

147

Sum=17424

Publishing Process of This Article

Item

Count

Browse

1190

Download

1064

Sum=2254

May 14, 2014 (publication date) through Jul 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. May 14, 2014; 20(18): 5442-5460
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5442

Table 2 Drug therapy for portopulmonary hypertension

Drug	Route of administration	Mechanism of action
Epoprostenol	Intravenous	Vasodilator, anti-platelet and anti-proliferative
Ambrisentan	Orally	Selective endothelin-A receptor antagonist
Bosentan	Orally	Endothelin-A and Endothelin B receptor antagonist
Sildenafil	Orally	Phosphodiesterase inhibitor
Iloprost	Inhaled	Prostacyclin analogue

Citation: Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol 2014; 20(18): 5442-5460
URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5442.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5442